“The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”Marina Pagnuzzi‐Boncompagni, Gilles Pagès|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 2